Descrição

Correlation between anti-selenoprotein P autoantibody titers and clinical symptom severity in CFS patients. Higher autoantibody levels are associated with more pronounced fatigue and hypothyroid-like symptoms.

Figure 3

Chart

Source Paper

Autoantibodies to selenoprotein P in chronic fatigue syndrome suggest selenium transport impairment and acquired resistance to thyroid hormone.

Redox biology (2023)

PMID: 37423160

DOI: 10.1016/j.redox.2023.102796

Cite This Figure

![Figure 3: Correlation between anti-selenoprotein P autoantibody titers and clinical symptom severity in CFS patients. Higher autoantibody levels are associated with more pronounced fatigue and hypothyroid-like symptoms.]()

> Source: Qian Sun et al. "Autoantibodies to selenoprotein P in chronic fatigue syndrome suggest selenium t." *Redox biology*, 2023. PMID: [37423160](https://pubmed.ncbi.nlm.nih.gov/37423160/)

<figure>
  <img src="" alt="Correlation between anti-selenoprotein P autoantibody titers and clinical symptom severity in CFS patients. Higher autoantibody levels are associated with more pronounced fatigue and hypothyroid-like symptoms." />
  <figcaption>Figure 3. Correlation between anti-selenoprotein P autoantibody titers and clinical symptom severity in CFS patients. Higher autoantibody levels are associated with more pronounced fatigue and hypothyroid-like symptoms.<br>  Source: Qian Sun et al. "Autoantibodies to selenoprotein P in chronic fatigue syndrome suggest selenium t." <em>Redox biology</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37423160/">37423160</a></figcaption>
</figure>

Evidências Relacionadas

Glutathione para Post-Viral Fatigue

Nota D · 3 estudos